Somnath Mukherjee to Bone Neoplasms
This is a "connection" page, showing publications Somnath Mukherjee has written about Bone Neoplasms.
Connection Strength
0.107
-
Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial. Lancet Oncol. 2017 04; 18(4):473-485.
Score: 0.107